Photo of Kate Hardey

Kate advises healthcare provider, pharmaceutical, medical device, dietary supplement and life sciences clients on regulatory and compliance matters and in all types of transactions including sales and acquisitions, as well as advising lenders and investors evaluating regulatory risks in cash flow and asset based debt financing transactions.

Health Information Highlight

Welcome back to our three-part series examining ways to efficiently identify, address and mitigate gaps in HIPAA compliance in transaction diligence. In Part I, we discussed four key diligence questions upon which buyers should focus their efforts in a transaction. In Part II, we reviewed considerations related to storage of and access

Health Information Highlight

Welcome back to our three-part series examining ways to efficiently identify, address and mitigate gaps in HIPAA compliance in transaction diligence. In Part I of this series, we discussed four key diligence questions upon which buyers should focus their efforts in a transaction. Here, we review considerations related to storage of

Health Information Highlight

Welcome to a three-part series that will examine several ways to efficiently identify, address, and mitigate gaps in HIPAA compliance in transaction diligence.

A target’s value is often held in its information and people. An increased risk of HIPAA enforcement means that privacy and security diligence should not be a “check the

HIPAA enforcement has been on the rise during the last several years, and the dollar impact of those settlements has continued to grow significantly. The Department of Health and Human Services, Office of Civil Rights (OCR) announced a record number of enforcement actions in 2016, including reaching its largest settlement to date in August 2016